在糖尿病护理中的特定人口葡萄糖预测与基于变压器的深度学习在边缘
IEEE transactions on biomedical circuits and systems
|January 1, 2024
概括
这项研究引入了一种新的可穿戴设备,用于在糖尿病管理中准确预测血糖. 该设备使用专门的AI模型,为糖尿病患者提供持续支持和改善生活质量.
科学领域:
- 生物医学工程 生物医学工程
- 医疗保健中的人工智能
- 糖尿病 技术 技术
背景情况:
- 使用持续血糖监测 (CGM) 进行实时血糖 (BG) 预测对于糖尿病管理至关重要.
- 现有的模型往往缺乏人口概括和有效嵌入到可穿戴设备中.
- 在2型糖尿病 (T2D) 中预测血糖是尚未探索的研究领域.
研究的目的:
- 开发一种特定于人群的BG预测模型,使用时间融合变压器 (TFT) 进行个性化糖尿病管理.
- 将这个TFT模型嵌入到一个低功耗,低成本的边缘计算可穿戴设备中.
- 评估设备在现实世界糖尿病护理中的性能和效率.
主要方法:
- 开发了一个特定于人口的BG预测模型,利用时间融合变压器 (TFT) 架构.
- 将训练有素的TFT模型集成到一个定制的低功耗芯片上的系统中,用于可穿戴设备.
- 启用了与CGM系统的无蓝牙通信,通过边缘计算实现实时BG预测.
主要成果:
- 嵌入式TFT模型在1型糖尿病 (T1D) 和T2D的临床数据集上表现出卓越的性能,预测误差最低.
- 由于内存和功耗最小,可穿戴设备在一次电池充电后实现了超过51天的连续运行.
- 该模型的预测根据个人人口统计数据进行了调整,从而增强了个性化.
结论:
- 拟议的TFT模型和可穿戴设备显示出改善糖尿病管理的巨大潜力.
- 该技术提供持续的决策支持,提高T1D和T2D患者的生活质量.
- 这种方法有效地解决了可穿戴糖尿病技术中现实世界的挑战.
相关概念视频
Diabetes Mellitus: Overview and Type I Subtype
2.7K
Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
2.7K
Diabetes Mellitus: Type 2 and Gestational
2.4K
Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
2.4K
Diabetes: Management and Pharmacotherapy
285
The therapy for diabetes aims to alleviate hyperglycemia-related symptoms, prevent acute metabolic decompensation, and reduce chronic end-organ complications. Glycemic control is evaluated through short-term (self-monitoring, continuous glucose monitoring) and long-term (A1c, fructosamine) metrics, enabling near real-time tracking of blood glucose levels and reflecting glycemic control over specific time frames.
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
285
Pathophysiology of Diabetes
941
Diabetes mellitus is a chronic metabolic disorder characterized by hyperglycemia. The four categories of diabetes are type 1 diabetes, type 2 diabetes, other specific types of diabetes, and gestational diabetes.
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
941
Glucose Homeostasis: Pancreatic Islets and Insulin Secretion
1.3K
The pancreatic islets comprising only 1%-2% of the volume are highly vascularized and innervated mini-organs. They contain five endocrine cell types, including β cells that secrete insulin, which is synthesized as a single polypeptide chain, preproinsulin, processed to proinsulin, and finally to insulin and C-peptide. This process is complex and regulated, involving the Golgi complex, the endoplasmic reticulum, and the secretory granules of the β cell.
Insulin and C-peptide are...
Insulin and C-peptide are...
1.3K
Diabetes: Symptoms, Diagnosis, and Complications
549
For most patients, experiencing several weeks of polyuria, polydipsia, fatigue, and significant weight loss may indicate the presence of diabetes. Furthermore, adults displaying the phenotypic appearance of type 2 diabetes (particularly those who are obese and not initially insulin-requiring), may have islet cell autoantibodies, suggesting autoimmune-mediated β cell destruction and a diagnosis of latent autoimmune diabetes of adults (LADA). The categorization of glucose homeostasis is...
549


